Market Research Logo

Autoimmune Hemolytic Anemia Therapeutics Market by Product and Geography - Global Forecast & Analysis 2019-2023

Global Autoimmune Hemolytic Anemia Therapeutics Market

About this market

Technavio’s autoimmune hemolytic anemia therapeutics market analysis considers sales from corticosteroids, monoclonal antibodies, and other products. Our analysis also considers the sales of autoimmune hemolytic anemia therapeutics in Asia, Europe, North America, and ROW. In 2018, the corticosteroids segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the strong therapeutic value of corticosteroids will play a significant role in the corticosteroids segment to maintain its market position. Also, our global autoimmune hemolytic anemia therapeutics market report looks at factors such as regulatory incentives, patient assistance programs, and adverse effects and complications associated with blood transfusion and splenectomy. However, lack of effective therapies, side-effects of drugs, and lack of specific diagnostic tests and awareness may hamper the growth of the autoimmune hemolytic anemia therapeutics industry over the forecast period.

Global Autoimmune Hemolytic Anemia Therapeutics Market

Overview

Patient Assistance Program

The high cost of therapeutics to treat autoimmune hemolytic anemia has encouraged pharmaceutical companies and governments of various countries to come up with financial assistance programs and reimbursements over the years. Financial assistance programs such as Obamacare in the US have minimized the treatment cost burden on patients. They help in providing the required medicines to patients and increase patient compliance to treatments including monoclonal antibodies such as rituximab. Such patient assistance program will lead to the expansion of the global autoimmune hemolytic anemia therapeutics market at a CAGR of over 9% during the forecast period.

R&D of Novel therapeutics

There is a limited number of drugs available for the treatment of autoimmune hemolytic anemia. This has driven the pharmaceutical companies and biotechnology researchers to invest in R&D activities to develop novel therapeutics such as fostamatinib and parsaclisib. These therapeutics are under development and have exhibited high efficacy and safety profile. This, in turn, will accelerate the approval of novel therapeutics for the treatment of autoimmune hemolytic anemia and have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global autoimmune hemolytic anemia therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global autoimmune hemolytic anemia therapeutics market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune hemolytic anemia therapeutics manufacturers, that include Amneal Pharmaceuticals Inc., Baxter International Inc., F. Hoffmann-La Roche Ltd., Incyte Corp., Kezar Life Sciences Inc., Mylan NV, Pfizer Inc., Rigel Pharmaceuticals Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.

Also, the autoimmune hemolytic anemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Corticosteroids - Market size and forecast 2018-2023
      • Table Corticosteroids - Market size and forecast 2018-2023 ($ millions)
      • Table Corticosteroids - Year-over-year growth 2019-2023 (%)
    • Monoclonal antibodies - Market size and forecast 2018- 2023
      • Table Monoclonal antibodies - Market size and forecast 2018-2023 ($ millions)
      • Table Monoclonal antibodies - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
    • R&D of novel therapeutics
    • Advances in murine models
    • Development of combination therapies
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Amneal Pharmaceuticals Inc.
      • Table Amneal Pharmaceuticals Inc. - Vendor overview
      • Table Amneal Pharmaceuticals Inc. - Business segments
      • Table Amneal Pharmaceuticals Inc. - Organizational developments
      • Table Amneal Pharmaceuticals Inc. - Segment focus
      • Table Amneal Pharmaceuticals Inc. - Key offerings
      • Table Amneal Pharmaceuticals Inc. - Key customers
    • Baxter International Inc.
      • Table Baxter International Inc. - Vendor overview
      • Table Baxter International Inc. - Business segments
      • Table Baxter International Inc. - Organizational developments
      • Table Baxter International Inc. - Segment focus
      • Table Baxter International Inc. - Key offerings
      • Table Baxter International Inc. - Key customers
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Vendor overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann-La Roche Ltd. - Organizational developments
      • Table F. Hoffmann-La Roche Ltd. - Geographic focus
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Key customers
    • Incyte Corp.
      • Table Incyte Corp. - Vendor overview
      • Table Incyte Corp. - Business segments
      • Table Incyte Corp. - Organizational developments
      • Table Incyte Corp. - Key offerings
      • Table Incyte Corp. - Key customers
    • Kezar Life Sciences Inc.
      • Table Kezar Life Sciences Inc. - Vendor overview
      • Table Kezar Life Sciences Inc. - Business segments
      • Table Kezar Life Sciences Inc. - Organizational developments
      • Table Kezar Life Sciences Inc. - Key offerings
      • Table Kezar Life Sciences Inc. - Key customers
    • Mylan NV
      • Table Mylan NV - Vendor overview
      • Table Mylan NV - Product segments
      • Table Mylan NV - Organizational developments
      • Table Mylan NV - Geographic focus
      • Table Mylan NV - Segment focus
      • Table Mylan NV - Key offerings
      • Table Mylan NV - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
    • Rigel Pharmaceuticals Inc.
      • Table Rigel Pharmaceuticals Inc. - Vendor overview
      • Table Rigel Pharmaceuticals Inc. - Business segments
      • Table Rigel Pharmaceuticals Inc. - Organizational developments
      • Table Rigel Pharmaceuticals Inc. - Key offerings
      • Table Rigel Pharmaceuticals Inc. - Key customers
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
      • Table Sanofi - Key customers
    • Teva Pharmaceutical Industries Ltd.
      • Table Teva Pharmaceutical Industries Ltd. - Vendor overview
      • Table Teva Pharmaceutical Industries Ltd. - Business segments
      • Table Teva Pharmaceutical Industries Ltd. - Organizational developments
      • Table Teva Pharmaceutical Industries Ltd. - Segment focus
      • Table Teva Pharmaceutical Industries Ltd. - Key offerings
      • Table Teva Pharmaceutical Industries Ltd. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook